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Paraneoplastic pemphigus (PNP) is an autoimmune
blistering disease that occurs in association with under-
lying neoplasms. PNP patients develop characteristic
autoantibodies directed against multiple antigens,
mostly identified as members of the plakin family of
cytoplasmic proteins (desmoplakin I and II, bullous
pemphigoid antigen I, envoplakin, and periplakin).
HD1/plectin, another member of the plakin family,
has not previously been detected in the characteristic
PNP antigen complex, which may relate to practical
difficulties associated with its large size (molecular
weight µ 500 kDa). In this study, a combination
of immunoprecipitation and immunoblot is used to
Paraneoplastic pemphigus (PNP) is an autoantibodymediated mucocutaneous blistering disease associatedwith underlying neoplasms, most commonly lymphoidmalignancies, thymomas, and poorly differentiated sar-comas (Anhalt et al, 1990; Anhalt, 1997). First described
in 1990, PNP is unique and distinct from classic forms of pemphigus
vulgaris or pemphigus foliaceus as defined by a combination of
clinical, histologic, and immunochemical criteria. Patients with
PNP develop characteristic autoantibodies against multiple antigens,
including a diagnostic antigen complex of high molecular weight
proteins with relative molecular weights of 250, 230, 210, 190,
and 170 kDa. Most of the proteins in this PNP antigen complex
have now been identified as members of the plakin family of
cytoplasmic proteins. The 250 kDa and 210 kDa antigens were
identified to be desmoplakins I and II, which are the major
cytoplasmic plaque proteins of desmosomes (Anhalt et al, 1990;
Oursler et al, 1992). The 230 kDa antigen was bullous pemphigoid
antigen 1, the major plaque protein of the epidermal hemidesmo-
some and also a target antigen in bullous pemphigoid (Anhalt
et al, 1990; Stanley, 1993). The 210 kDa antigen identified by
immunoprecipitation was subsequently recognized to be a doublet,
of which the slower migrating band was desmoplakin II and the
faster migrating band, the one that is recognized by immunoblotting
(Hashimoto et al, 1995), was later shown to be envoplakin by
cDNA cloning (Ruhrberg et al, 1996; Kim et al, 1997). The
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demonstrate that HD1/plectin is also recognized by
sera from PNP patients. Thirteen of 16 PNP sera tested
were positive for HD1/plectin compared with none of
43 control sera (11 pemphigus vulgaris, 11 pemphigus
foliaceus, 11 bullous pemphigoid, and 10 normal indi-
viduals). Combined with our recent finding that
desmoglein 3 and desmoglein 1 are cell surface target
antigens in PNP, this demonstration of plectin/HD1
as another component of the antigen complex in PNP
confirms that PNP is an autoimmune disease against
desmoglein and plakin family molecules. Key words:
autoimmunity/desmoglein/plakins. J Invest Dermatol 112:
153–156, 1999
190 kDa antigen was recently shown to be periplakin (Ruhrberg
et al, 1997; Borradori et al, 1998; Kiyokawa et al, 1998; Mahoney
et al, 1998), whereas the 170 kDa antigen is a transmembrane cell
surface protein that has yet to be identified (Anhalt, 1997). Most
recently, the desmosomal cadherins, desmoglein 3 and desmoglein
1, which are the autoimmune target in pemphigus vulgaris and
foliaceus (Amagai et al, 1991; Amagai, 1996), have also been
identified as cell surface targets in PNP (Amagai et al, 1998). We
also demonstrated that autoantibodies against desmoglein 3 in PNP
sera play a pathogenic role in inducing the loss of cell adhesion of
keratinocytes to cause blister formation (Amagai et al, 1998).
The plakin family are a group of structurally and immunologically
related intermediate filament-associated proteins that play an
important role in the anchorage of cytoskeleton to filament
attachment sites on plasma membranes (Ruhrberg and Watt, 1997).
Plakins have characteristic C-terminal structures that localize to
intermediate filaments, whereas the amino terminus is believed
to determine localization to components of desmosomes and
hemidesmosomes. Plectin is an extremely high molecular weight
plakin that was recently cloned from rat C-6 glioma cells (Wiche
et al, 1991) and the corresponding amino acid sequence has
homology at the carboxy terminus to desmoplakin and bullous
pemphigoid antigen 1 (Green et al, 1992). Plectin has a wide tissue
distribution and its precise cytoplasmic localization appears to
depend on both cell type and the antibody used. This may be
because different antibodies recognize different plectin isoforms.
HD1 was first described as a 500 kDa component of the hemidesmo-
some (Owaribe et al, 1991; Uematsu et al, 1994). HD1 localizes
to the innermost region of the hemidesmosome plaque, where
interaction with keratin intermediate filaments is apparent (Hieda
et al, 1992). It seems likely that plectin and HD1 may be identical
or isoforms of the same protein because of their similar molecular
weight and colocalization in hemidesmosomes (Owaribe et al,
1991; Wiche et al, 1991); however, although the primary sequence
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of human plectin has been described (McLean et al, 1996; Smith
et al, 1996), the primary sequence of HD1 remains unknown, so
the true identity of HD1 is not yet proven. Increasingly, however,
evidence suggests that HD1 is an isoform of plectin (Gache et al,
1996; McLean et al, 1996) and it appears to be the form of plectin
that interacts with the β4 integrin subunit in hemidesmosomes
(Sanchez-Aparicio et al, 1997). We therefore refer to it as HD1/
plectin.
Because the characteristic antigen complex in PNP includes
multiple members of the plakin family, we questioned whether
HD1/plectin was similarly a target for autoimmune attack in this
disease. The large size of HD1 (µ500 kDa) makes it difficult to
detect this protein not only by regular immunoprecipitation, but
also by immunoblot, so it is possible that HD1/plectin was
overlooked previously. In this study we optimized the assay
conditions for detection of anti-HD1/plectin autoantibodies and
used the combined technique of immunoprecipitation-immuno-
blotting (IP-IB) to examine 16 sera from PNP patients. Our studies
show that the majority of PNP sera (13 of 16) immunoprecipitate
HD1/plectin and indicate that any member of the plakin family
can be the autoimmune target for PNP.
MATERIALS AND METHODS
Human sera Sera were obtained from 16 patients with clinically,
histologically, and immunopathologically typical PNP. Control sera were
also obtained from 11 patients with typical pemphigus vulgaris, 11 patients
with pemphigus foliaceus, 11 patients with bullous pemphigoid, and 10
normal individuals.
Monoclonal antibodies An anti-HD1 mouse monoclonal antibody,
HD-121 (Hieda et al, 1992), and an anti-desmoplakin mouse monoclonal
antibody, 11–5F (Parrish et al, 1987) (a kind gift from Dr. D.R. Garrod,
Manchester University, Manchester, U.K.) were used for the immuno-
precipitation and immunodetection of HD1 and desmoplakins I and
II, respectively. HD-121 is specific for HD1/plectin integrated into
hemidesmosomes (Hieda et al, 1992).
Immunoprecipitation and immunoblotting Immunoprecipitation-
immunoblotting (IP-IB) was performed using keratinocyte extracts as
substrate. The keratinocyte extracts were prepared from KU8 cells, a
squamous carcinoma cell line (Tsukamoto, 1989) with 1% Triton X-100
in PBS containing complete protease inhibitor cocktail tablet (Boehringer,
Mannheim, Germany). Typically, 2 ml of extracts were prepared from one
confluent 9 cm dish. Two hundred microliters of KU8 extracts was
incubated with 10 µl of each PNP, pemphigus vulgaris, pemphigus foliaceus,
bullous pemphigoid, or normal control sera at room temperature for 3 h
and then immunoprecipitated with protein A Sepharose CL4B (Pharmacia
Biotech, Uppsala, Sweden) overnight at 4°C. The extracts were also
incubated with anti-HD1 monoclonal antibody, HD-121 as a positive
control for the detection of HD1/plectin.
The immunoprecipitants were applied to 5% SDS-PAGE and blotted
overnight to a PVDF membrane (Millipore, Bedford, MA). HD1/plectin
was detected with monoclonal antibody HD-121 diluted 1:60 in Tris-
buffered saline. Desmoplakin I and II were detected with monoclonal
antibody 11–5F diluted 1:200 in Tris-buffered saline. The membrane was
incubated with HD-121 or a 1:1 mixture of HD-121 and 11–5F overnight
at 4°C, washed thoroughly with Tris-buffered saline with 0.05% Tween20,
and alkaline phosphatase-conjugated goat anti-mouse IgG used as second
antibody. Proteins were visualized using a standard alkaline phosphatase
detection system.
RESULTS
PNP sera contain autoantibodies against HD1/plectin
Initially, we attempted to detect HD1/plectin by conventional
immunoblot using keratinocyte extracts as a substrate with PNP
sera. We optimized conditions, including a long blotting time
(overnight) and a long incubation time with antibodies (4C°
overnight); however, we failed to see a clear positive band for
HD1/plectin. We considered that this failure was partly due to the
insufficient amount of antigen on the blotted membrane and partly
due to the loss of conformation of HD1/plectin during the
immunoblotting. Therefore, we performed IP-IB to overcome the
above problems.
Figure 1. Detection of HD1/plectin using the combined immuno-
precipitation and immunoblot assay with PNP sera. Keratinocyte
extracts were incubated with anti-HD1 monoclonal antibody (P), PNP
sera (PNP), or normal control sera (N), and precipitated with protein
A-Sepharose. Immunoprecipitants were subjected to immunoblot analysis
with anti-HD1 monoclonal antibody. The arrow indicates the approximate
500 kDa band for HD1/plectin. Molecular weight standards indicated by
bars are 200 and 97 kDa.
Thirteen of 16 PNP sera tested (81.3%), immunoprecipitated an
appoximately 500 kDa band, which was detected by immunoblot-
ting with anti-HD1 monoclonal antibody, HD-121 (Fig 1). To
validate our IP-IB method for detection of HD1/plectin in
PNP sera and to assess the relative sensitivity with which it
can immunoprecipitate other PNP antigens, we simultaneously
examined the PNP sera for anti-desmoplakin antibodies (Fig 2).
We chose anti-desmoplakin antibodies because they have been
considered an essential serologic marker for the diagnosis of PNP
(Oursler et al, 1992). Using monoclonal antibody 11–5F, 13 of 16
PNP sera were able to immunoprecipitate desmoplakin I (250 kDa)
and eight of 16 immunoprecipitated desmoplakin II (210 kDa).
The lower detection rate of desmoplakin II, when compared with
that of desmoplakin I, is probably due to its lower expression level
in keratinocytes (Angst et al, 1990). There was one PNP serum
that detected only HD1/plectin but not desmoplakins, and one
PNP serum that failed to detect HD1/plectin but did detect
desmoplakin I. In contrast, none of 11 pemphigus vulgaris sera, 11
pemphigus foliaceus sera, 11 bullous pemphigoid sera, or 10 sera
from normal individuals were positive against HD1/plectin (Fig 1).
These findings indicate that HD1/plectin is recognized by PNP
sera as frequently as desmoplakins.
DISCUSSION
This study provides strong evidence that HD1/plectin is a target
autoantigen in PNP. The characteristic antigen complex that defines
PNP includes desmoplakins I and II, bullous pemphigoid antigen
1, envoplakin, and periplakin – five proteins that all have related
sequences and that are all members of the plakin gene family.
Therefore it was relevant to ask whether HD1/plectin is similarly
a target for autoimmune attack in PNP. It seemed possible that
previously this 500 kDa protein was not described as an antigen
for PNP because of practical difficulties associated with immunopre-
cipitating and immunoblotting such a large protein. In this study we
have demonstrated that 13 of 16 PNP sera contained autoantibodies
directed against HD1/plectin, whereas none were detected in sera
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Figure 2. Simultaneous detection of HD1/plectin and desmoplakin
I, II using the combined immunoprecipitation and immunoblot
assay with PNP sera. Immunoprecipitation was performed in the same
way as in Fig 1. Immunoblotted membrane was incubated with a mixture
of anti-HD1 monoclonal antibody and anti-desmoplakin monoclonal
antibody. The arrow indicates the approximate 500 kDa band for HD1/
plectin and closed circles indicate desmoplakin I and II. Molecular weight
standards indicated by bars are 200 and 97 kDa.
from 43 control patients or normal individuals. The frequency of
anti-HD1/plectin autoantibodies was as high as that of anti-
desmoplakin autoantibodies in PNP sera. A possibility that HD1/
plectin was coimmunoprecipitated with other plakins by autoanti-
bodies against them in PNP sera is minimal because anti-HD1
monoclonal antibody, HD-121, has been shown to immuno-
precipitate only the 500 kDa HD1 polypeptide without any
coprecipitated bands, indicating that HD1 does not complex with
other molecules in keratinocyte extracts (Uematsu et al, 1994). We
conclude that HD1/plectin is another autoimmune target of PNP.
Our findings are supported by the study of Mahoney et al (1998)
who examined PNP sera with fusion proteins of the homologous
tail region of five plakin family members, including plectin. Their
plectin tail-glutathione S-transferase fusion protein reacted with
three of five PNP sera. Although they were unclear of the
significance of this finding, our data suggest PNP autoanti-
bodies bind native plectin and not just denatured plectin-GST on
immunoblot.
It is intriguing to consider why PNP patients should develop
auto-antibodies against all members of the plakin family. There
could be a cross-reacting epitope common to all plakins or
there might be separate autoantibodies for each plakin protein.
Alternatively, one could also speculate that initially there might be
a single autoantibody with the subsequent evolution of epitope
spreading and development of further anti-plakin autoantibodies.
Mahoney et al partially addressed this question of unique or shared
epitopes using recombinant plakin proteins and demonstrated that
PNP sera have antibodies against unique and shared epitopes on
periplakin and envoplakin (Mahoney et al, 1998). Their data and
the inconsistency with which all PNP sera precipitate all PNP
autoantigens (Anhalt et al, 1990; Fullerton et al, 1992) make it
unlikely that a single autoantibody cross-reacts with all plakin
proteins. In keeping with this, we found two PNP sera that reacted
either with HD1/plectin or with desmoplakins, but not both.
Why PNP patients should develop antibodies to plakin molecules
is not known, and the pathophysiologic relevance of these anti-
plakin autoantibodies is also unclear. The intracellular location of
plakin proteins makes it unlikely that anti-plakin autoantibodies
initiate pathology in PNP. Recently, we have demonstrated that
desmoglein 3 and desmoglein 1 are cell surface target antigens in
PNP (Amagai et al, 1998). It seems more likely that anti-desmoglein
antibodies play this primary role in initiating blister formation. One
could speculate that damage to cell membranes induced by anti-
desmoglein IgG, provides access into the cell for anti-plakin
autoantibodies that then bind to their target antigens, inhibiting
their functions and perhaps precipitating some of the unique features
of PNP, such as keratinocyte necrosis.
By demonstrating that HD1/plectin is also a target molecule
of PNP, PNP is defined as an anti-desmoglein and anti-plakin
autoimmune disease. It is an important initial step towards unveiling
the fundamental mechanism on the tolerance break in autoimmune
diseases to characterize and define the autoimmune target molecules
in PNP.
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